Presentation is loading. Please wait.

Presentation is loading. Please wait.

Urso for PSC - CON Christopher L. Bowlus, MD Professor and Chief

Similar presentations


Presentation on theme: "Urso for PSC - CON Christopher L. Bowlus, MD Professor and Chief"— Presentation transcript:

1 Urso for PSC - CON Christopher L. Bowlus, MD Professor and Chief
Division of Gastroenterology and Hepatology University of California Davis

2 Guilty Until Proven Innocent
We should NOT use a treatment until it is proven safe and effective. All treatments have risk/adverse effects Often hard to measure (Celebrex, Omeprazole) Not all treatments have benefits Improving liver tests is not a benefit

3 New Drug Approval - FDA Substantial evidence from appropriately designed and analyzed trials Demonstrate an improvement in how a patient feels, functions, or survives After > 20 years of study, Urso has still not met these standards

4 Urso Improves Liver Tests
PSC patients with lower liver tests live longer….. ….so doesn’t this mean that Urso will make me live longer? Not necessarily

5 What we want Urso to do Without Urso With Urso Alkaline Phosphatase

6 What Urso may actually be doing
Alkaline Phosphatase Without Urso Alkaline Phosphatase With Urso

7 Normal Alkaline Phosphatase Predicts Better Prognosis Regardless of Urso
Lindstrom L, et al. Clinic Gastroenterol Hepatol

8 If Urso works, wouldn’t we know by now???
Didn’t work in the US Didn’t work in Scandnavia 12/9/2018

9 PBC but not PSC Transplants have decreased since Urso was approved
Accessed April 2, 2013

10 High-dose Urso has unintended consequences
12/9/2018

11 Weighing the risks and benefits?
Benefit of Urso Risk of disease progression Risk of Urso Cost of Urso Take Urso Don’t Take Urso


Download ppt "Urso for PSC - CON Christopher L. Bowlus, MD Professor and Chief"

Similar presentations


Ads by Google